United States · FDA National Drug Code directory
buprenorphine transdermal system
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47781-408_7f83c8aa-7590-e2fe-4998-55323eadd112
- Product NDC
- 47781-408
- Form
- PATCH, EXTENDED RELEASE
- Composition / generic term
- buprenorphine
- Labeler
- Alvogen Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220517 / 20270131
Source-listed ingredients
- BUPRENORPHINE — 20 ug/h
These values do not establish equivalence or a dose recommendation.
Packages
- 4 POUCH in 1 CARTON (47781-408-04) / 1 PATCH in 1 POUCH (47781-408-11) / 168 h in 1 PATCH · 47781-408-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →